BioXXmed Competitors and Similar CompaniesClear all
BioXXmed's competitors and similar companies include Vitrolife, Annexon Biosciences and Themis Bioscience.
 BioXXmed BioXXmed (formerly known as CytoTools) is a biotechnology company engaged in biomedicine investments. |  Vitrolife Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. |  Annexon Biosciences Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. | ||
Founding Date | Founding Date N/A | Founding Date 1981 | Founding Date 2011 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Darmstadt, DE HQ | Locations Västra Frölunda, SE HQ | Locations Brisbane, US HQ | Locations Wien, AT HQ |
Employees | Employees 1 | Employees 1,150 | Employees 10041% increase | Employees 373% decrease |
Valuation ($) | Valuation ($) 151.5 k | Valuation ($) 3.1 b | Valuation ($) 799.8 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) €17k (FY, 2025) | Revenue (est.) kr3.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods kr1.3b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €31k (FY, 2025) | Gross profit kr2.2b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (€365k) (FY, 2025) | Net income (kr5b) (FY, 2025) | Net income ($206.7m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 179m | Total funding raised $ 81.8m |
For sources of this data, please see the company profile
View Company Profiles
Vitrolife
HQ
Västra Frölunda, SE
Employees
1,150
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
View companyAnnexon Biosciences
HQ
Brisbane, US
Employees
100↑ 41% increase
Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
View company
Themis Bioscience
HQ
Wien, AT
Themis Bioscience develops vaccines against tropical infections.
View company